0001469709-20-000006 Sample Contracts

EXCLUSIVE LICENSE AGREEMENT for MSK's technology “Novel Compounds for Inhibition of Id”

Exclusive License Agreement • February 11th, 2020 • AngioGenex, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Exclusive License Agreement
• Filed
  February 11th, 2020
• Company
  AngioGenex, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York